PT
Peter A. Thompson (Director) filed 9 Form 4 reports in the trailing twelve months (1 purchase, 8 sales), most often in Sionna Therapeutics, Inc. (SION). The largest single filing was $22.9M of SION (510,583 sh across 3 lots, as filed), executed Apr 14. The median gap between execution and disclosure was 2 days. Data as of Nov 8 2026.
Add to watchlistReturn, ttmiAverage return per filing, trailing twelve months
–
purchases not yet priced
Delay-adjustediThe same average, entered at disclosure dates
–
purchases not yet priced
Filings, ttm
9
1 buys · 8 sells
Median delay
2d
execution → disclosure
Volume, ttmiDollar value disclosed in the trailing twelve months
$65.7M
shares × price, as filed
Last traded
Nov 2
Filed Nov 4
Median ADV $10.0M across their filed names
100% of their measured filings could not be priced (delisted or unquoted names). The returns above cover only what still trades.
Open performance→Volume by month
Buys $34.9M
Sells $60.3M
Shares × price, as filed · by filing month · past 24 months
Sectors filed on
Healthcare
9 filings
Sector per market data · by filing · past 12 months
Most traded names
SIONRecent filings
SIONSALE
Sionna Therapeutics, Inc.
View filing →
$4.7M106,473 sh across 2 lots
Exec Nov 24 2025
Filed Nov 26 2025 · 5:30 PM ET CRVSSALE Corvus Pharmaceuticals, Inc. View filing → $4.9M
1,176,332 sh × $4.16
Exec Jun 27 2025
Filed Jul 1 2025 · 5:30 PM ET EWTXPURCHASE Edgewise Therapeutics, Inc. View filing → $10.0M
496,771 sh across 2 lots
Exec Apr 3 2025
Filed Apr 4 2025 · 5:30 PM ET SIONPURCHASE Sionna Therapeutics, Inc. View filing → $9.9M
550,000 sh × $18.00
Exec Feb 10 2025
Filed Feb 10 2025 · 5:30 PM ET